Stock research log
$NVO Insider Trading
Novo Nordisk A/S
15
Alerts Listed
0
Insider Buys 30d
0
Insider Sells 30d
This page is InsiderWatch’s research log for NVO: the alerts we sent on this stock, timestamped, plus recent insider buying and selling reported to the SEC on Form 4.
Price and Our Alerts
$NVO price
Daily closing prices
3M change
-14.7%
1Y high
$63.98
1Y low
$35.29
Our alerts
15
in this window
Prices from public market data and may be delayed. Markers show the days our alerts on this stock fired. Not investment advice.
Our Alerts on $NVO
| Sent (ET) | Call | Alert |
|---|---|---|
| Nov 4, 1:38 AM | NEUTRAL | Novo Nordisk raises full-year outlook on GLP-1 demand |
| Sep 30, 5:53 AM | NEUTRAL | Real-world data supports Novo's Wegovy pill switch |
| Sep 29, 12:52 AM | NEUTRAL | Novo licenses Hengrui oral GLP-1/GIP obesity drug |
| Sep 24, 5:51 PM | NEUTRAL | Novo Nordisk CEO warning sinks stock 8% |
| Sep 22, 11:24 AM | NEUTRAL | Novo's CagriSema beats Lilly's Zepbound in Phase III |
| Sep 21, 4:39 AM | NEUTRAL | Novo falls 7% despite $23B obesity sales target |
| Sep 18, 12:31 PM | NEUTRAL | Novo wins CHMP nod for hemophilia A drug denecimig |
| Sep 17, 10:31 AM | NEUTRAL | CHMP backs EU approval of Novo's haemophilia drug |
| Sep 14, 11:16 AM | NEUTRAL | Novo Nordisk wins China MASH approval for Wegovy |
| Sep 11, 5:19 PM | BEARISH | Morgan Stanley cuts Novo Nordisk to Sell |
| Sep 10, 2:26 PM | NEUTRAL | Novo wins first China GLP-1 MASH label for Wegovy |
| Sep 8, 9:41 AM | BULLISH | Novo Nordisk semaglutide hits goal in pediatric obesity trial |
| Sep 7, 6:12 AM | BULLISH | Novo Nordisk semaglutide hits Phase 3 goal in young children |
| Sep 2, 10:58 AM | NEUTRAL | Citi flags Novo Nordisk GLP-1 script slowdown |
| Aug 27, 4:20 AM | NEUTRAL | China accepts Novo Nordisk weight-loss drug application |
Every alert we sent on NVO is listed after a short delay, in the order it went out. The call shown is the one in the alert as sent.
Congress Trading in $NVO
Members of Congress who disclosed trades in NVO under the STOCK Act since we began tracking. Each name links to that member’s full page. Amounts are the disclosed ranges (see how the ranges work) and filings can arrive up to 45 days after the trade.
| Member | Action | Amount |
|---|---|---|
| Kevin HernHouse | SELL | $1,001 - $15,000 |
| Kevin HernHouse | SELL | $1,001 - $15,000 |
| Scott Scott FranklinHouse | BUY | $1,001 - $15,000 |
Disclosed amounts are ranges. Filing and trade dates, who in the household traded, and full histories are part of the subscriber dashboard.
See the research log across all stocks, this week’s insider buying, or the congress trading tracker.
Get the Next NVO Alert When It Fires.
Everything here is already public. Subscribers usually got it within minutes. Pro members get every alert. Free for 7 days, cancel any time.
Try Free for 7 DaysInsiderWatch is an informational research service based on publicly available information only and is not financial, investment, legal, or tax advice. The call shown is a reading of the event, not a recommendation to trade.